Wird geladen...
P04.19 METABOLIC IMPACT OF ANTI-ANGIOGENIC AGENTS ON GLIOMA CELLS
BACKGROUND: The direct impact on glioma cells metabolism of drugs targeting the VEGF pathway, such as Bevacizumab (Bev) or VEGFR Tyrosine Kinase Inhibitor (TKI), is poorly known. Glioma cells not only secrete high levels of vascular endothelial growth factor (VEGF)but also express VEGF receptors (VE...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185496/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.151 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|